Ethics can play a significant role in the financial management of a sport organization. Sport managers have a responsibility to act ethically and legally with respect to the organizations that they manage. Unfortunately, some people connected to the sport industry have violated this ethical responsibility. One all-too-common issue relates to performance-enhancing drugs (PED), and PED usage among professional athletes continues to trouble the sport industry. Examples in 2013 alone included the MLB's investigation of players Alex Rodriguez, Ryan Braun, and Melky Cabrera and their association with Anthony Bosch and the Biogenesis clinic (Thompson, Madden, O'Keeffe, & Red, 2013). The sport of cycling remains under intense scrutiny. In June of 2013, the U.S. government filed suit against Lance Armstrong in an attempt to reclaim US$40 million in sponsorship dollars and bonuses awarded to Armstrong and his team members during their Tour de France bids from 1998 to 2004 (Dye, 2013). Additionally, Vijay Singh allegedly used a prohibited deer antler spray, and the PGA Tour withheld nearly US$100,000 of his prize earnings in response to the allegations. Singh filed a lawsuit against the organization, citing unfair treatment during the investigation (Crouse, 2013).However, when detrimental issues such as PED use arise, should those same players be rewarded for their efforts?

• What financial ramifications should they incur in the face of such use?
• For instance, should Armstrong repay his salary and bonuses?
• What responsibilities and remedies do sport organizations have when handling these issues?